Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLEKHO1 encodes a scaffolding protein with a pleckstrin homology domain that mediates protein-protein interactions, subcellular localization, and key signaling events[1][4]. It recruits protein kinase CK2 to the plasma membrane, modulates transcription (AP-1/c-Jun), and influences apoptosis via caspase-mediated cleavage and nuclear translocation[1]. PLEKHO1 is also essential for bone formation, immune cell polarization, and the regulation of cell cycle and protein degradation. In various cancers, PLEKHO1 is dysregulated and contributes to tumorigenesis, with its roles being highly context-dependent (can be tumor suppressive or promotive depending on cancer type); genetic variants are linked to metabolic and cardiovascular risk[2][4].
Inhibition of PLEKHO1 (e.g., siRNA) leads to increased bone formation via suppression of Smad-dependent BMP signaling. Knockdown impairs cell viability by inhibiting Hippo and JNK signal transduction pathways (in cancer models). Regulation of AP-1/c-Jun, PI3K/Akt pathway, and protein degradation via proteasome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain containing, family O member 1 (PLEKHO1).